Volume : 13, Issue : 04, April – 2026

Title:

FORMULATION AND CHARACTERIZATION OF FAST DISSOLVING ORAL FILMS OF RIZATRIPTAN FOR EFFECTIVE TREATMENT OF MIGRAINE

Authors :

Taqeer Aahmad*, B. K. Dubey, Sunil Kumar Shah, Deepak Basedia

Abstract :

Migraine is a common neurological disorder requiring rapid onset of action for effective management. The present study aimed to formulate and characterize fast dissolving oral films of Rizatriptan to improve patient compliance and provide quick relief. Fast dissolving oral films (F1–F6) were prepared using suitable film-forming polymers and evaluated for physicochemical and mechanical properties. All formulations showed acceptable appearance, thickness, and weight uniformity. Folding endurance, tensile strength, moisture content, disintegration time, and drug content were found to be within acceptable limits. Among all formulations, F5 exhibited superior characteristics, including highest folding endurance (240 ± 4), lowest disintegration time (50 ± 3 seconds), and maximum drug content (99.00 ± 0.26%). The in vitro drug release study of optimized formulation F5 showed rapid release, with 47.12% drug release within 1 minute and 99.12% release within 15 minutes, indicating its suitability for immediate therapeutic action. Stability studies confirmed that the formulation remained stable over a period of three months with minimal variation in drug content. In conclusion, the developed fast dissolving oral film of rizatriptan offers a promising alternative to conventional dosage forms by providing rapid drug release, improved patient compliance, and effective management of migraine.
Keywords: Rizatriptan, Fast dissolving oral film, Migraine, Solvent casting method, Rapid drug release, Disintegration time, Oral drug delivery, Film formulation, Patient compliance, Stability study.

Cite This Article:

Please cite this article in press Taqeer Aahmad et al., Formulation And Characterization Of Fast Dissolving Oral Films Of Rizatriptan For Effective Treatment Of Migraine., Indo Am. J. P. Sci, 2026; 13(04).

REFERENCES:

1. Villar-Martinez MD, Goadsby PJ. Pathophysiology and therapy of associated features of migraine. Cells. 2022 Sep 5;11(17):2767.
2. Mungoven TJ, Henderson LA, Meylakh N. Chronic migraine pathophysiology and treatment: a review of current perspectives. Frontiers in Pain Research. 2021 Aug 25;2:705276.
3. Hargreaves R, Longmore J, Beer M, Shepheard S, Cumberbatch M, Williamson D, Stanton J, Razzaque Z, Sohal B, Street L, Seabrook G. The pharmacology and mechanisms of action of rizatriptan. Monographs in Clinical Neuroscience. 2000;17:141-61.
4. Bhattarai M, Gupta AK. Fast dissolving oral films: a novel trend to oral drug delivery system. Sunsari Technical College Journal. 2015;2(1):58-68.
5. Lakshmi PK, Lavanya D, Ali MMH (2014) Effect of synthetic superdisintegrants and natural polymers in the preparation of Donepezil hydrochloride fast disintegration films. Int Cur Pharm J 3: 243-246.
6. Seeta Devi. A, Naga jyothi. P, Charan Raju. P, Kiran kumar. P et al., Formulation and evaluation of fast dissolving oral films of Fluoxetine hydrochloride, J Global Trends Pharm Sci 2016; 7(3):3394-3400.
7. Shimoda H, Taniguchi K, Nishimura M, Matsuura K, Tsukioka T, “Preparation of fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy”, Eur J Pharm Biopharm, 2009; 73(3): 361-5.
8. Rama Krishna K,” Formulation and In-vitro evaluation of Loratidine fast dissolving films,” IAJPS, 2014; 1(4): 275- 283.
9. Rajni Bala, Shailesh Sharma, “Formulation optimization and evaluation of Fast dissolving film of aprepitant by using design of experiment,” Bulletin of faculty of pharmacy, 2018, Cairo university 2018;56: 159- 168.
10. Syed Naiem Raza, Aabid Husain Kar, Taha Umair Wanii and Nisar Ahmad Khan,” Formulation and evaluation of mouth dissolving films of Losartan potassium using 32 factorial design,” IJPSR, 2019; 10(3): 1402-1411.
11. Dasari Nirmala, Swapna Nandhini, M. Sudhakar. Design and evaluation of fast dissolving oral films of Zolpidem by solvent casting method. Asian J. Pharm. Res. 2016; 6(2): 67-71.
12. Maheswari KM, Devineni PK, Deekonda S, Shaik S, Uppala NP, Nalluri BN. Nalluri, Development and evaluation of mouth dissolving films of amlodipine besylate for enhanced therapeutic efficacy, Journal of pharmaceutics, article ID 520949. 2014;1-10.
13. Dinge A, Nagarsenker M. Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity, AAPS Pharm Sci Tech. 2008;9(2):349–56.
14. Hema Chaudhary., Samita Gauri., Permender Rathee., Vikash Kumar., Development and optimization of fast dissolving oro-dispersible films of granisetron HCl using Box-Behnken statistical design, Bullet. Faculty Pharm., Cairo University. 2013;51:193–201.